Singapore government has initiated the process to amend the Maritime and Port Authority of Singapore (MPA) Act 1996. The Maritime and Port Authority of Singapore (Amendment) Bill was introduced for First Reading in Parliament on 6 October 2026.
The key to developing disease-specific relapse insurance lies in unlocking the value of medical data, according to Ms Pan Jiqi, director of the Commercial Insurance Collaborative Innovation Department at the Shanghai Institute of Clinical Innovation and Transformation.
Great Eastern has welcomed Mr Hicham Raissi as Managing Director, Group Head of General and Group Insurance.
The 35th General Arab Insurance Federation General Conference (GAIF35), held at the Dead Sea, Jordan, concluded yesterday with the release of eight major recommendations calling for a greater focus on emerging risks and the deployment of technology.
Thailand's regulator, the Office of Insurance Commission (OIC), is now enhancing the readiness of the insurance industry in the face of rising cyber threats, including digital attacks, the use of AI to discover vulnerabilities, attacks through external service providers and risks arising from increasingly interconnected digital ecosystems.
The Monetary Authority of Singapore (MAS) has issued its Guidelines on Artificial Intelligence (AI) Risk Management to support responsible AI adoption in Singapore's financial sector, as AI technologies are developing rapidly and being adopted in financial services with increasing scale and sophistication. The Guidelines took effect on 7 October 2027.
The DIFC Insurance Association (DIFCIA) has announced the appointment of Mr Ahmed Rajab, Founder and CEO of SHIELDS Miller (formerly SHIELDS Reinsurance Brokers), as Chairman of the Association.
The Central Bank of Jordan (CBJ) is currently working to develop regulatory frameworks for licensing digital insurance platforms and updating the legal framework governing online insurance operations.
AI is accelerating health and medical research; personalised medicine is now a reality and new treatments are pushing the boundaries of what medicine can achieve, but a major question remains: whether they can prove, manufacture, finance and safely deliver them at scale?
Following an on-site inspection carried out by Hong Kong's Insurance Authority (IA) under the Anti-Money Laundering and Counter-Terrorist Financing Ordinance (Cap. 615) (AMLO)1,2, FWD Life Insurance Company (Bermuda) has been ordered to pay a pecuniary penalty of HK$19.5m ($2.5m).